CRISPR/Cas systems for genomic Editing, biochemical Sensing, Bioanalysis, and diagnostics

被引:0
|
作者
Baig, Mirza Muhammad Faran Ashraf [1 ]
Chair, Sek Ying [1 ]
Chien, Wai Tong [1 ]
机构
[1] Chinese Univ Hong Kong, Fac Med, Asia Pacific Genet & Genom Nursing Ctr, Nethersole Sch Nursing,Croucher Lab Human Genom, Hong Kong, Peoples R China
关键词
CRISPR/Cas systems; Bacterial immune system; Gene modifications; Novel bio-analysis techniques; Medical; environmental; and agricultural; applications; NUCLEIC-ACID; CAS SYSTEM; DELIVERY; COVID-19; TECHNOLOGY; OPTIMIZATION; CRISPR-CAS9; RECOGNITION; INHIBITION; EXPRESSION;
D O I
10.1016/j.microc.2024.112638
中图分类号
O65 [分析化学];
学科分类号
070302 ; 081704 ;
摘要
Clustered Regularly Interspaced Short Palindromic Repeats (CRISPR) systems were known for the last few decades as genome editing tools. These CRISPR systems used Cas enzymes to edit genes by cutting/editing target DNA/RNA strands of specific sequences. The CRISPR/Cas systems were originally found in various species of archaea/bacteria which helped organisms to break foreign DNA/RNA to protect themselves from viral/bacterial attacks. Later, scientists further developed these CRISPR/Cas systems by attaching fluorophores/colorimetric reporters to the DNA probes in designing various bioanalytical approaches to target, cut, identify, and analyze different types of DNAs and RNAs in biological, and clinical samples. During the last decade, technically advanced, robust, and bioanalytical technologies of clinical importance derived from CRISPR/Cas systems were developed, and established, for instance, point of care testing (POCT) devices had been in the market such as CRISPR/Cas-based rapid lateral flow assays; rapid assay testing kits (RAT Kits such as for the detection of COVID19); colorimetric, fluorescence; or biosensing techniques for bioanalysis. These CRISPR/Cas-based techniques detected analytes with as low concentration as micromolar, nanomolar, picomolar, and even of attomole levels in the patient's blood, urine, nasal, buccal, or saliva samples as a breakthrough for the rapid diagnosis of diseases. Moreover, CRISPR/Cas technique-based diagnostic tools such as SHERLOCK (Specific High-sensitivity Enzymatic Reporter Un-Locking) and DETECTR (DNA Endonuclease Targeted CRISPR Trans-Reporter) enabled sensitive detection of nucleic acids in the variety of clinical and environmental samples. Thus, for programmable nature of CRISPR/Cas systems and for the tailored biosensing solution, these innovations in detections had successful applications in infectious disease diagnosis, and genetic testing, in addition to the environmental monitoring, microbial detections, food safety/agricultural implications, and crop production.
引用
收藏
页数:16
相关论文
共 50 条
  • [1] Genomic editing in Burkholderia multivorans by CRISPR/Cas9
    Ferreira, Mirela R.
    Queiroga, Vasco
    Moreira, Leonilde M.
    APPLIED AND ENVIRONMENTAL MICROBIOLOGY, 2024, 90 (02)
  • [2] Evolution of CRISPR/Cas Systems for Precise Genome Editing
    Hryhorowicz, Magdalena
    Lipinski, Daniel
    Zeyland, Joanna
    INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES, 2023, 24 (18)
  • [3] CRISPR-Cas Systems and Genome Editing: Beginning the Era of CRISPR/Cas Therapies for Humans
    Karpov, Dmitry S.
    INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES, 2024, 25 (10)
  • [4] Development and application of CRISPR/Cas9 technologies in genomic editing
    Zhang, Cui
    Quan, Renfu
    Wang, Jinfu
    HUMAN MOLECULAR GENETICS, 2018, 27 (R2) : R79 - R88
  • [5] Editing and investigating genomes with TALE and CRISPR/Cas systems: Applications of artificial TALE and CRISPR-Cas systems
    Giovannangeli, Carine
    Concordet, Jean-Paul
    METHODS, 2014, 69 (02) : 119 - 120
  • [6] CRISPR-Cas12a system in fission yeast for multiplex genomic editing and CRISPR interference
    Zhao, Yu
    Boeke, Jef D.
    NUCLEIC ACIDS RESEARCH, 2020, 48 (10) : 5788 - 5798
  • [7] Multiplexed CRISPR-Cas9 and CRISPR-Cas12a Systems for Genome Editing in Plants
    Li, Gen
    Qi, Yiping
    IN VITRO CELLULAR & DEVELOPMENTAL BIOLOGY-ANIMAL, 2023, 59 : S67 - S67
  • [8] Directed Evolution of CRISPR/Cas Systems for Precise Gene Editing
    Liu, Rongming
    Liang, Liya
    Freed, Emily F.
    Gill, Ryan T.
    TRENDS IN BIOTECHNOLOGY, 2021, 39 (03) : 262 - 273
  • [9] CRISPR/Cas gene editing and delivery systems for cancer therapy
    Li, Yingjie
    Zhou, Shiyao
    Wu, Qinjie
    Gong, Changyang
    WILEY INTERDISCIPLINARY REVIEWS-NANOMEDICINE AND NANOBIOTECHNOLOGY, 2024, 16 (01)
  • [10] CRISPR-Cas systems for genome editing of mammalian cells
    Mani, Indra
    Arazoe, Takayuki
    Singh, Vijai
    REPROGRAMMING THE GENOME: CRISPR-CAS-BASED HUMAN DISEASE THERAPY, 2021, 181 : 15 - 30